Five Good Reasons to Choose Siegfried
- Siegfried is a leading global Custom Development and Manufacturing Organization (CDMO), with Net Sales of CHF 1.1 billion and more than 3600 employees worldwide
- Siegfried’s integrated offering covers development and manufacturing in both Drug Substances (Active Pharmaceutical Ingredients) as well as Drug Products (Finished Dosage Forms)
- The CDMO market offers attractive growth dynamics: low cyclicality, low volatility, resilient growth and high structural profitability
- The pharmaceutical industry is changing, leading to favorable trends for the CDMO market
- It is Siegfried’s ambition to consistently deliver robust growth and execute on value accretive M&A to outgrow market and competitors